Taurodesoxycholic acid is a bile acid derivative within the ursodeoxycholic acid class, commonly studied for its role in mitigating liver inflammation and supporting cellular function in various cholestatic… Read more
![Chemical structure of 2-((6R)-3-((7-(N,N-Dimethylsulfamoyl)benzo[c][1,2,5]oxadiazol-4-yl)amino)-6-((3R,5S,7R,8R,9S,10S,12S,13R,14S,17R)-3,7,12-trihydroxy-10,13-dimethylhexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)heptanamido)ethane-1-sulfonic Acid](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F1255908-35-0-2-6R-3-7-NN-Dimethylsulfamoylbenzoc125oxadiazol-4-ylamino-6-3R5S7R8R9S10S12S13R14S17R-3712-trihydroxy-1013-dimethylhexadecahydro-1H-cyclo.png&w=3840&q=75)





Taurodesoxycholic acid is a bile acid derivative within the ursodeoxycholic acid class, commonly studied for its role in mitigating liver inflammation and supporting cellular function in various cholestatic conditions. This category includes high-quality reference standards, analytical impurities, and stable isotope labelled compounds essential for the rigorous quality control and impurity profiling of this pharmaceutical agent. Laboratories utilize these reference materials during method validation and quantitative analysis to ensure accurate identification and measurement of active ingredients and degradation products in complex matrices. By incorporating stable isotope labelled standards, researchers can improve precision in mass spectrometry-based assays, facilitating reliable data collection for stability studies and pharmacokinetics. These analytical tools support precise regulatory compliance and provide the necessary benchmarks to maintain stringent safety and efficacy standards throughout the development and manufacturing of tauroursodeoxycholic acid drug formulations.